Dr Varun Sethi outlines some of the most important trends in ASEAN healthcare today and how DKSH, as a historic business services provider, is adapting its offering to meet them.
Singapore has always been considered the bellwether of driving innovation in the region, which remains the case. In terms of new oncology and immunology products, Singapore is almost always willing to be a first mover, taking affordability and access into account, and is clearly a reference standard across Asia on speed to market
